INS and Autoimmunity: Additionally, Mamchak and colleagues proved that anti-CD3 monoclonal antibody treatment with oral insulin intake improved the blood glucose level of diabetic NOD mice by increasing regulatory T cells and decreasing CD4 + CD25+ T cells, indicating a suppression of autoimmunity [132].